Keratoconjunctivitis sicca (KCS), or dry eye disease (DED), is a common ocular disease prompting millions of individuals to seek ophthalmological care. Regardless of the underlying etiology, dry eye has been shown to be associated with abnormalities in the pre-corneal tear film and subsequent inflammatory changes in the entire ocular surface including the adnexa, conjunctiva and cornea.
AxeroVision’s Programs have been designed to target the underlying inflammation of DED, thus providing a more meaningful clinical effect for patients, and not just the symptoms.
